Enfermedad cardiovascular aterosclerótica y sexualidad

Urología Colombiana

article

Sebastián Galvis-Acevedo¹  Daniela Rivas-Escobar¹  Liliana Arias-Castillo¹  Herney Andrés García-Perdomo² 

[1] Departamento de Medicina Familiar, Escuela de Medicina, Universidad del Valle;Departamento de Cirugía/Urología, Escuela de Medicina, Universidad del Valle

关键词: enfermedad cardiovascular;    sexualidad;    antidepresivos;    inhibidores de la fosfodiesterasa 5;   

DOI  :  10.1055/s-0042-1746202

学科分类：社会科学、人文和艺术（综合）

来源: Thieme

【 摘 要 】

Atherosclerotic cardiovascular disease is the leading cause of death worldwide and the leading cause of disability-adjusted life years (DALYs). Its risk factors are very prevalent in the population, and its occurrence has been associated with sexual dysfunction in both men and women, because they share a similar pathophysiological mechanism in the case of erectile dysfunction in men and potentially in female sexual dysfunction. Furthermore, associated mental disorders (mainly anxiety and depression) and the adverse effects of antihypertensive drugs and antidepressants also contribute to sexual dysfunction. On the other hand, phosphodiesterase 5 inhibitors (PDE5is) have shown safety and cardiovascular benefits in men, and in women there is growing evidence of their usefulness in female sexual dysfunctions. The present review describes the implications of atherosclerotic cardiovascular disease and its treatment on the sexual lives of men and women, the cardiovascular effects of the treatments for sexual dysfunctions, and patient counseling.

【 授权许可】

CC BY|CC BY-NC-ND